Pre-clinical and early-phase clinical studies of curcumin as chemopreventive agent for endemic cancers in Taiwan.
Hsu
Chih-Hung
CH
Department of Oncology, National Taiwan University Hospital, Taipei.
Chuang
Shuang-En
SE
Hergenhahn
Manfred
M
Kuo
Min-Liang
ML
Lin
Jen-Kun
JK
Hsieh
Chang-Yao
CY
Cheng
Ann-Lii
AL
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000821:virology; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control*; D003474:Curcumin / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D019587:Dietary Supplements; D004854:Herpesvirus 4, Human / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008113:Liver Neoplasms / Q000517:prevention & control*; D051379:Mice; D008809:Mice, Inbred C3H; D009303:Nasopharyngeal Neoplasms / Q000517:prevention & control*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D003474:Curcumin